Listed

Immunovant, Inc.

IMVTNasdaqCIK 1764013HealthcareFiscal year ends Mar 31

Reports and events: 145 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Immunovant, Inc., Reports and events
FiledFormWhat it isAccession number
2023-09-2817:23 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-23-245815
2023-09-2607:45 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001764013-23-000114
2023-08-2316:48 ET8-K5.07 Shareholder vote results0001764013-23-000097
2023-08-1007:19 ET10-QQuarterly reportPeriod 2023-06-300001764013-23-000092
2023-08-1007:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001764013-23-000090
2023-06-2607:26 ETDEF 14AProxy statementPeriod 2023-08-210001764013-23-000072
2023-05-2207:10 ET10-KAnnual reportPeriod 2023-03-310001764013-23-000065
2023-05-2207:03 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001764013-23-000063
2023-03-2707:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001764013-23-000026
2023-02-0307:17 ET10-QQuarterly reportPeriod 2022-12-310001764013-23-000022
2023-02-0307:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001764013-23-000020
2023-01-0908:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001764013-23-000003
2022-12-0807:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001764013-22-000143
2022-11-0407:21 ET10-QQuarterly reportPeriod 2022-09-300001764013-22-000140
2022-11-0407:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001764013-22-000139
2022-10-0417:28 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-257688
2022-09-2810:49 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001764013-22-000118
2022-09-0706:39 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001764013-22-000114
2022-08-1917:01 ET8-K5.07 Shareholder vote results0001764013-22-000108
2022-08-0507:17 ET10-QQuarterly reportPeriod 2022-06-300001764013-22-000085
2022-08-0507:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001764013-22-000083
2022-06-3007:08 ETDEF 14AProxy statementPeriod 2022-03-310001764013-22-000066
2022-06-0807:09 ET10-KAnnual reportPeriod 2022-03-310001764013-22-000059
2022-06-0807:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001764013-22-000057
2022-03-3007:44 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001764013-22-000033
2022-02-0407:22 ET10-QQuarterly reportPeriod 2021-12-310001764013-22-000031
2022-02-0407:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001764013-22-000029
2022-01-0715:57 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001764013-22-000007
2022-01-0507:38 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001764013-22-000002
2021-12-3007:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001764013-21-000129
2021-11-2316:27 ET8-K1.01 Entry into a material agreement0001764013-21-000127
2021-11-1708:36 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001764013-21-000123
2021-11-0507:48 ET10-QQuarterly reportPeriod 2021-09-300001764013-21-000119
2021-11-0507:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001764013-21-000117
2021-09-2708:23 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001764013-21-000102
2021-09-1507:23 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001764013-21-000098
2021-08-1216:37 ETDEF 14AProxy statementPeriod 2021-09-090001764013-21-000083
2021-08-0907:09 ET10-QQuarterly reportPeriod 2021-06-300001764013-21-000079
2021-08-0906:56 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001764013-21-000077
2021-08-0208:23 ETSC 13D/AOwnership report, active investor, amended0001104659-21-098576
2021-08-0208:09 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001764013-21-000061
2021-07-1317:14 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001764013-21-000058
2021-06-0107:40 ET10-KAnnual reportPeriod 2021-03-310001764013-21-000052
2021-06-0107:36 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001764013-21-000051
2021-03-0808:00 ETSC 13D/AOwnership report, active investor, amended0001104659-21-032967
2021-02-1608:24 ET8-K2.02 Results of operations0001764013-21-000019
2021-02-1608:24 ET10-QQuarterly reportPeriod 2020-12-310001764013-21-000018
2021-02-0206:52 ET8-K8.01 Other events0001764013-21-000012
2020-11-1208:30 ET10-QQuarterly reportPeriod 2020-09-300001764013-20-000063
2020-11-1208:28 ET8-K2.02 Results of operations0001764013-20-000062

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:26 ET. Listed shows no prices and gives no investment advice.